HighTower Advisors’s Guardant Health GH Stock Holding History

HighTower Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40	Closed	-$3K	–	3510
2021 Q4	$3K	Sell	40 -5,460	-99%	-$565K	﹤0.01%	3217
2021 Q3	$69K	Buy	+5,500	New	+$653K	﹤0.01%	2900
2021 Q2	–	Sell	-30	Closed	-$129K	–	3251
2021 Q1	$129K	Buy	+30	New	+$4.53K	﹤0.01%	2711

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's GH Position: Q1 2026 in Review

HighTower Advisors reduced its Guardant Health (GH) stake by 17% in Q1 2026, selling an estimated $495K and leaving 23,446 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

HighTower Advisors first reported a position in GH in Q2 2019 and has held it in 28 quarters since. The position peaked at $10.5M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

HighTower Advisors held 23,446 shares of Guardant Health worth $2.17M as of Q1 2026.
HighTower Advisors sold 4,930 Guardant Health shares in Q1 2026, an estimated $495K.
Guardant Health made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1670 holding.
HighTower Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
HighTower Advisors's Guardant Health position peaked at $10.5M in Q1 2021.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.